Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

SCARLET FEVER ANTITOXIN

SCARLET FEVER ANTITOXIN It is evident from the numerous inquiries that are received at the Willard Parker Hospital that the true value of scarlet fever antitoxin is not generally known; with this in view, the following observations are presented. The series presented consists of 465 consecutive and unselected cases, in which 250 of the patients did not receive antitoxin. I feel, therefore, that the real value of the antitoxin can be obtained. All patients with scarlet fever who were admitted to the hospital did not receive antitoxin, for it was apparent that in the moderately severe and in the mild cases the patients did not show sufficient toxemia to warrant the treatment. Furthermore, the serum rash that may appear often causes more subjective symptoms than the disease per se. Therefore, it was decided that the temperature and the clinical observations should govern the administration of the antitoxin. As a rule, patients who had http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American journal of diseases of children American Medical Association

Loading next page...
 
/lp/american-medical-association/scarlet-fever-antitoxin-B78le0CVv0

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1928 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0096-8994
eISSN
1538-3628
DOI
10.1001/archpedi.1928.01920190021003
Publisher site
See Article on Publisher Site

Abstract

It is evident from the numerous inquiries that are received at the Willard Parker Hospital that the true value of scarlet fever antitoxin is not generally known; with this in view, the following observations are presented. The series presented consists of 465 consecutive and unselected cases, in which 250 of the patients did not receive antitoxin. I feel, therefore, that the real value of the antitoxin can be obtained. All patients with scarlet fever who were admitted to the hospital did not receive antitoxin, for it was apparent that in the moderately severe and in the mild cases the patients did not show sufficient toxemia to warrant the treatment. Furthermore, the serum rash that may appear often causes more subjective symptoms than the disease per se. Therefore, it was decided that the temperature and the clinical observations should govern the administration of the antitoxin. As a rule, patients who had

Journal

American journal of diseases of childrenAmerican Medical Association

Published: Jan 1, 1928

There are no references for this article.